Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07513519 · ClinicalTrials.gov registry record · NA

Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial

A NA study, sponsored by BioMérieux.

Recruiting
Registry status
NA
Development phase
800
Enrollment target

NCT07513519: Recruiting NA study, sponsored by BioMérieux.

NCT07513519 is a NA study that is actively recruiting participants, run by BioMérieux. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07513519, a NA study, is actively recruiting participants, sponsored by BioMérieux.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target

Study Summary

This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R/ST assay in the urgent care setting. A hybrid effectiveness-implementation type 1 study primarily focuses on the effectiveness of an intervention (e.g., use of Spotfire R/ST) but also simultaneously allows for the collection of data on the barriers and facilitators of implementing the Spotfire R/ST test in the real-world urgent care setting.

Primary Outcome

The percent of episodes for patients one year and older with a diagnosis of a respiratory condition that results in an antibiotic prescribing event. (Note: while the HEDIS measure includes all patients greater than 3 months of age, AFC's electronic health record (EHR) stores age as whole years. Excluding patients with a reported age of 0 from the baseline data resulted in only 0.03% of observations lost.)

Interventions

  • DEVICE SPOTFIRE R/ST Diagnostic Test

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2025-12-22
Est. Completion 2026-04
Phase NA
BioMérieux

8 total trials

What NCT07513519 shows while recruiting

NCT07513519 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).

The record links to 0 conditions, and to 1 intervention - of which SPOTFIRE R/ST Diagnostic Test is the first listed.

NCT07513519 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07513519 about?

NCT07513519 is a clinical study titled "Impact of a Multiplex Respiratory PCR Test on Outcomes for Patients Presenting With Respiratory Illness in the Urgent Care Setting: A Hybrid-Effectiveness Quasi-Experimental Trial". This research study will use a hybrid effectiveness-implementation type 1 design to assess effectiveness of the Spotfire R/ST assay in the urgent care setting. A hybrid effectiveness-implementation type 1 study primarily focuses on the effectiveness of an intervention (e.g., use of Spotfire R/ST) bu...

What is the current status of trial NCT07513519?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2025-12-22. Estimated completion is 2026-04.

What interventions are being tested in trial NCT07513519?

The interventions under investigation include: SPOTFIRE R/ST Diagnostic Test (DEVICE).

Who is sponsoring clinical trial NCT07513519?

This trial is sponsored by BioMérieux, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07513519's enrollment target sits among peer trials

800 135th of 2000 higher than 1,861 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07513519, the US trial registry maintained by the National Library of Medicine. NCT07513519 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.